Nautilus Biotechnology, Inc is a Seattle-based company that is revolutionizing the field of proteomics by developing a platform that unlocks the full scale of the proteome, enabling breakthroughs in basic biology, medicine, and biotechnology. Their solution offers the sensitivity, dynamic range, and ease of use necessary to make the vast scale and value of the proteome accessible to all researchers.
With a focus on accelerating the drug development process, enabling diagnostics for precision medicine, and democratizing proteomics for basic science research, Nautilus Biotechnology aims to provide integrated workflows, straightforward data, and cloud-based analysis tools to help researchers gain a comprehensive understanding of the proteome and its dynamic nature.
Generated from the website